[시장보고서]세계의 IoT 의료기기 시장 : 제품별, 유형별, 접속 기술별, 최종 사용자별, 지역별 예측(-2030년)

세계의 IoT 의료기기 시장 : 제품별, 유형별, 접속 기술별, 최종 사용자별, 지역별 예측(-2030년)

IoT Medical Devices Market by Product(Wearable (Vital Sign (BP, Glucose, ECG, Oximeter), Resp., Fetal), Implant(Neuro, Cardiac-Defib, Pacemaker) Pumps), Connectivity(Bluetooth, WiFi), End User(Hospital, Nursing Home) & Region - Global Forecast to 2030

상품코드 : 1752398 해당 상품은 즉시 배송 가능합니다

리서치사 : MarketsandMarkets

발행일 : 2025년 06월

페이지 정보 : 영문 330 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,950

￦ 7,384,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650

￦ 9,920,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 12,158,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,918,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 IoT 의료기기 시장 규모는 2025년 650억 8,000만 달러에서 2030년까지 1,547억 4,000만 달러에 이를 것으로 예측되며, 예측 기간 중 CAGR은 18.9%가 될 것으로 보입니다. 이 시장은 특히 원격 의료의 보급에 따라 환자의 지속적이고 실시간 모니터링에 대한 수요가 높아지고 있기 때문에 급성장하고 있습니다. 최근 기술 혁신은 웨어러블 디바이스와 임베디드 디바이스에서 헬스케어 시스템으로의 효율적인 데이터 수집 및 전송을 가능하게 합니다. 적극적이고 분산된 케어가 가능해져 병원에서의 재입원의 감소로 이어집니다. 또한, 만성 질환의 이환율의 상승과 세계의 고령화에 의해 가정과 임상의 두 환경에서 이러한 기술의 이용이 확대되고 있습니다.

조사 범위
조사 대상 연도	2024-2030년
기준연도	2024년
예측 기간	2024-2030년
검토 단위	금액(10억 달러)
부문	제품별, 유형별, 연결 기술별, 최종 사용자별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

그러나 시장은 레거시 의료 IT 인프라와의 통합 복잡성, HIPAA 및 GDPR(EU 개인정보보호규정)과 같은 데이터 프라이버시 규정에 대한 대응, 연결이 진행되는 생태계에서 환자 정보를 보호하기 위한 견고한 사이버 보안 유지의 필요성 등의 과제에 직면하고 있습니다.

2024년, 병원 및 클리닉 부문은 IoT 의료기기 시장에서 주요 최종 사용자 부문으로 떠오르며, 그 지위는 향후 몇 년 동안 유지될 것으로 예측됩니다. IoT 대응 기술을 채택함으로써 이러한 시설은 실시간 데이터 모니터링, 원격 케어 기능, 합리화된 임상 업무를 통해 환자의 결과를 향상시킬 수 있습니다. 이를 통해 신속한 개입과 보다 효과적인 케어를 제공할 수 있습니다. 또한, IoT를 전자 의료기기(EHR)나 임상 의사결정 플랫폼과 통합함으로써 데이터의 정확성이 향상되고 케어팀간의 제휴가 강화됩니다. 결과적으로 병원 및 클리닉은 성능을 향상시키고, 컴플라이언스를 확보하고, 보다 신속하고 개별화된 환자 관리를 제공하기 위해 IoT 기술에 많은 투자를 하고 있습니다.

Bluetooth 지원 IoT 기술은 IoT 의료기기 시장에서 가장 빠르게 성장하는 연결 옵션으로 빠르게 성장하고 있습니다. Bluetooth는 단거리 데이터 교환을 위한 신뢰성이 높고 비용 효율적인 방법이 되고 있습니다.

아시아태평양은 예측 기간 동안 IoT 의료기기 시장에서 가장 빠른 성장을 이룰 것으로 예측됩니다. 인프라의 개선을 목표로 한 정부의 이니셔티브가 스마트 병원 및 디지털 건강 플랫폼에 대한 많은 투자와 함께 연결 의료기기의 도입 확대로 이어지고 있습니다. 또한, 강화된 통신 네트워크와 디지털 의료 서비스에 대한 지지적인 규제 틀이, IoT 기반의 솔루션의 도입을 촉진하고 있습니다.

본 보고서에서는 세계 IoT 의료기기 시장에 대해 조사했으며, 제품별, 유형별, 연결기술별, 최종 사용자별, 지역별 동향 및 시장 진출기업 프로파일 등을 정리했습니다.

소개
시장 역학
업계 인사이트
기술 분석
Porter's Five Forces 분석
주요 이해관계자와 구매 기준
규제 분석
밸류체인 분석
생태계 분석
가격 분석
특허 분석
사례 연구 분석
2025-2026년의 주된 회의와 이벤트
고객의 비즈니스에 영향을 미치는 동향/혼란
2025년 미국 관세의 영향-IoT 의료기기 시장

제6장 IoT 의료기기 시장(제품별)

소개
바이탈 사인 모니터링 장치
영상 시스템
이식형 심장 디바이스
환자 모니터
호흡기계 기기
주입 펌프
태아 모니터링 장치
신경학적 장치
인공호흡기
마취기
보청기
기타

제7장 IoT 의료기기 시장(유형별)

소개
거치형 디바이스
내장형 디바이스
웨어러블 디바이스
기타

제8장 IoT 의료기기 시장(접속 기술별)

소개
WI-FI
Bluetooth
ZIGBEE
기타

제9장 IoT 의료기기 시장(최종 사용자별)

소개
병원 및 클리닉
노인 홈, 간병 첨부 고령자용 주택, 장기 케어 센터, 재택 케어 시설
기타

제10장 IoT 의료기기 시장(지역별)

소개
북미
- 북미의 거시경제 전망
- 미국
- 캐나다
유럽
- 유럽의 거시 경제 전망
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타
아시아태평양
- 아시아태평양의 거시 경제 전망
- 중국
- 일본
- 인도
- 기타
라틴아메리카
- 라틴아메리카의 거시 경제 전망
- 브라질
- 멕시코
- 기타
중동 및 아프리카
- 중동 및 아프리카의 거시경제 전망
- GCC 국가
- 기타

제11장 경쟁 구도

소개
주요 진입기업의 전략/강점
수익 분석, 2024년
시장 점유율 분석, 2024년
기업평가 매트릭스: 주요 진입기업, 2024년
기업평가 매트릭스: 스타트업/중소기업, 2024년
평가 및 재무지표
브랜드/소프트웨어 비교
경쟁 시나리오

제12장 기업 프로파일

주요 진출기업
- MEDTRONIC
- GE HEALTHCARE
- KONINKLIJKE PHILIPS NV
- ABBOTT
- BOSTON SCIENTIFIC CORPORATION
- OMRON CORPORATION
- BAXTER INTERNATIONAL, INC.
- BIOTRONIK
- JOHNSON & JOHNSON
- NIHON KOHDEN CORPORATION
- SIEMENS HEALTHINEERS AG
- HONEYWELL INTERNATIONAL, INC.
- ALIVECOR, INC.
- DRAGERWERK AG & CO. KGAA
- NONIN
- RESMED
- MASIMO
- I-SENS, INC.
- ICU MEDICAL, INC.
기타 기업
- AMD GLOBAL TELEMEDICINE
- IHEALTH LABS
- AEROTEL MEDICAL SYSTEMS
- HUNTLEIGH HEALTHCARE LIMITED
- INFINIUM MEDICAL
- HAMILTON MEDICAL

제13장 부록

>JHS

영문 목차

영문목차

The global IoT medical devices market is projected to reach USD 154.74 billion by 2030, up from USD 65.08 billion in 2025, reflecting a CAGR of 18.9% during this period. The market is growing rapidly due to an increasing demand for continuous and real-time patient monitoring, particularly with the wider adoption of telehealth. Recent innovations in low-energy sensors, 5G networks, and edge computing have made it possible to efficiently collect and transmit data from wearable and implantable devices to healthcare systems. These advancements enable more proactive and decentralized care, leading to fewer hospital readmissions. Furthermore, the rising incidence of chronic conditions and an aging global population are driving the greater use of these technologies in both home and clinical settings.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2024-2030
Units Considered	Value (USD billion)
Segments	Product, type, connectivity technology, end user, region
Regions covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

However, the market faces challenges, such as the complexity of integrating with legacy health IT infrastructure, compliance with data privacy regulations like HIPAA and GDPR, and the need to maintain strong cybersecurity to protect patient information in an increasingly connected ecosystem.

"The hospitals & clinics segment, under the IoT medical devices market, is expected to register the fastest growth during the forecast period."

In 2024, the hospitals & clinics segment emerged as the leading end user segment in the IoT medical devices market, a position it is expected to maintain in the coming years. This leadership is primarily due to the increasing demand for advanced diagnostic, monitoring, and treatment tools within healthcare facilities. By adopting IoT-enabled technologies, these institutions can enhance patient outcomes through real-time data monitoring, remote care capabilities, and streamlined clinical operations. The ability to continuously track patient vital signs and chronic health conditions allows for quicker interventions and more effective care delivery. Additionally, the integration of IoT with electronic health records (EHRs) and clinical decision-making platforms improves data accuracy and fosters better coordination among care teams. Key factors driving this trend include the push for higher efficiency, rising patient volumes, and the necessity to meet stringent regulatory and quality standards. As a result, hospitals and clinics are making substantial investments in IoT technologies to improve performance, ensure compliance, and provide more responsive, personalized patient care.

"Bluetooth-enabled IoT technology is projected to dominate the IoT medical devices market during the forecast period."

Bluetooth-enabled IoT technology is rapidly emerging as the fastest-growing connectivity option in the IoT medical devices market. This growth is primarily driven by its energy efficiency, easy integration, and wide compatibility with smartphones, tablets, and wearable healthcare devices. As more healthcare organizations adopt connected solutions for continuous monitoring and patient interaction, Bluetooth has become a reliable and cost-effective method for short-range data exchange. It plays a vital role in devices such as fitness trackers, mobile diagnostic equipment, and home health monitoring tools, where low power consumption and consistent data transfer are crucial.

"Asia Pacific is expected to register fastest market growth during the forecast period."

The Asia Pacific region is expected to experience the fastest growth in the IoT medical devices market during the forecast period. This growth is primarily driven by the rapid adoption of digital healthcare technologies, including IoT and artificial intelligence. Government initiatives aimed at improving healthcare infrastructure, combined with significant investments in smart hospitals and digital health platforms, are leading to the increased deployment of connected medical devices. Additionally, the rising demand for remote monitoring solutions, fueled by a growing elderly population and an increase in chronic health conditions, is further propelling this trend. Furthermore, enhanced telecommunications networks and supportive regulatory frameworks for digital health services are facilitating the implementation of IoT-based solutions. As a result, Asia-Pacific is emerging as a key player in the global expansion of the IoT medical device industry.

The breakdown of primary participants is as mentioned below:

By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
By Region - North America: 32%, Asia Pacific: 32%, Europe: 26%, Latin America: 5% and Middle East & Africa: 5%

Key Players in the IoT Medical Devices Market

The key players functioning in the IoT medical devices market include Medtronic (Ireland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Abbott (US), Boston Scientific Corporation (US), OMRON Corporation (Japan), Baxter International Inc. (US), BIOTRONIK (Germany), Johnson & Johnson Private Limited (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Honeywell International Inc. (US), AliveCor, Inc. (US), Dragerwerk AG & Co. KGaA (Germany), Nonin (US), AMD Global Telemedicine (US), iHealth Labs Inc (US), Aerotel Medical Systems (1998) Ltd. (Israel), i-SENS, Inc. (Korea), Huntleigh Healthcare Limited (UK), ResMed (US), Masimo (US), Infinium Medical (US), ICU Medical, Inc. (US), and Hamilton Medical (Switzerland).

Research Coverage

The report analyzes the IoT medical devices market and aims to estimate the market size and future growth potential of various market segments based on product, type, connectivity technology, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will provide valuable insights for both, established companies and new or smaller firms, helping them understand market trends and dynamics. By doing so, they can increase their market share. Companies that purchase this report can employ one or more of the strategies outlined below to enhance their positions in the market.

This report provides insights on:

Analysis of key drivers: Drivers (government initiatives to promote digital health), restraints (high deployment cost of connected medical devices), opportunities (low doctor-to-patient ratio in several countries), and challenges (data security issues) are key factors influencing the growth of the IoT medical devices market
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the IoT medical devices market
Market Development: Comprehensive information on the lucrative emerging markets, product, type, connectivity technology, end user, and region
Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the IoT medical devices market
Competitive Assessment: In-depth assessment of market ranking, growth strategies, product offerings, and capabilities of the leading players in the IoT medical devices market like Medtronic (Ireland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Abbott (US), and Boston Scientific Corporation (US)

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DESIGN
- 2.1.1 RESEARCH DATA
- 2.1.2 SECONDARY SOURCES
  - 2.1.2.1 Key data from secondary sources
- 2.1.3 PRIMARY SOURCES
  - 2.1.3.1 Key data from primary sources
  - 2.1.3.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 LIMITATIONS
2.5 MARKET SHARE ANALYSIS
2.6 ASSUMPTIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 IOT MEDICAL DEVICES MARKET OVERVIEW
4.2 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY TYPE AND COUNTRY
4.3 GEOGRAPHIC GROWTH OPPORTUNITIES IN IOT MEDICAL DEVICES MARKET
4.4 REGIONAL MIX: IOT MEDICAL DEVICES MARKET
4.5 IOT MEDICAL DEVICES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Government initiatives to promote digital health
  - 5.2.1.2 Growing need for cost-containment in healthcare delivery
  - 5.2.1.3 Rising focus on patient engagement and patient-centric healthcare
  - 5.2.1.4 Evolution of high-speed networking technologies
  - 5.2.1.5 Growing focus on patient safety
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High deployment costs of connected medical devices
  - 5.2.2.2 Lack of skilled IT personnel across healthcare organizations
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Low doctor-to-patient ratio in several countries
- 5.2.4 CHALLENGES
  - 5.2.4.1 Data security issues
  - 5.2.4.2 Data management and interoperability concerns
5.3 INDUSTRY INSIGHTS
- 5.3.1 INCREASING NUMBER OF PRODUCT LAUNCHES
- 5.3.2 GROWING INTEGRATION OF CLOUD PLATFORMS AND SAAS IN HEALTHCARE ECOSYSTEM
- 5.3.3 INCREASING NUMBER OF COLLABORATIONS TO DRIVE INNOVATION
5.4 TECHNOLOGY ANALYSIS
5.5 PORTER'S FIVE FORCES ANALYSIS
- 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.5.2 BARGAINING POWER OF SUPPLIERS
- 5.5.3 BARGAINING POWER OF BUYERS
- 5.5.4 THREAT OF NEW ENTRANTS
- 5.5.5 THREAT OF SUBSTITUTES
5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.6.2 BUYING CRITERIA
5.7 REGULATORY ANALYSIS
- 5.7.1 NORTH AMERICA
  - 5.7.1.1 US
  - 5.7.1.2 Canada
- 5.7.2 EUROPE
- 5.7.3 ASIA PACIFIC
  - 5.7.3.1 Japan
  - 5.7.3.2 China
  - 5.7.3.3 India
5.8 VALUE CHAIN ANALYSIS
5.9 ECOSYSTEM ANALYSIS
5.10 PRICING ANALYSIS
5.11 PATENT ANALYSIS
- 5.11.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
- 5.11.2 LIST OF MAJOR PATENTS
5.12 CASE STUDY ANALYSIS
- 5.12.1 CASE STUDY 1: ADVANCING WOUND MEASUREMENT ACCURACY IN HEALTHCARE WITH IOT TECHNOLOGY
- 5.12.2 CASE STUDY 2: EMPOWERING PATIENT-CONTROLLED PAIN MEDICATION ADMINISTRATION WITH IOT TECHNOLOGY
- 5.12.3 CASE STUDY 3: IMPROVING MATERNAL AND FETAL CARE WITH IOT-DRIVEN MONITORING SOLUTIONS
5.13 KEY CONFERENCES AND EVENTS, 2025-2026
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.15 IMPACT OF 2025 US TARIFFS-IOT MEDICAL DEVICES MARKET
- 5.15.1 INTRODUCTION
- 5.15.2 KEY TARIFF RATES
- 5.15.3 PRICE IMPACT ANALYSIS
- 5.15.4 IMPACT ON COUNTRY/REGION
  - 5.15.4.1 US
  - 5.15.4.2 Europe
  - 5.15.4.3 Asia Pacific
- 5.15.5 IMPACT ON END-USE INDUSTRIES

6 IOT MEDICAL DEVICES MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 VITAL SIGNS MONITORING DEVICES
- 6.2.1 BLOOD GLUCOSE MONITORS
  - 6.2.1.1 Preference for continuous glucose monitoring to drive market
- 6.2.2 ECG/HEART RATE MONITORS
  - 6.2.2.1 Rising incidence of CVD to drive market growth
- 6.2.3 BLOOD PRESSURE MONITORS
  - 6.2.3.1 Growing prevalence of hypertension and obesity to fuel market
- 6.2.4 MULTIPARAMETER MONITORS
  - 6.2.4.1 Rising preference for home care to drive demand
- 6.2.5 OXIMETERS
  - 6.2.5.1 Increasing focus on self-monitoring to drive market
6.3 IMAGING SYSTEMS
- 6.3.1 NEED TO TRANSMIT DATA FOR REMOTE VIEWING TO SUPPORT MARKET GROWTH
6.4 IMPLANTABLE CARDIAC DEVICES
- 6.4.1 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
  - 6.4.1.1 Growing geriatric population to boost demand
- 6.4.2 PACEMAKERS
  - 6.4.2.1 Rising number of cardiac patients to drive demand
- 6.4.3 IMPLANTABLE CARDIAC MONITORS
  - 6.4.3.1 Ease of remote monitoring to drive demand
6.5 PATIENT MONITORS
- 6.5.1 GROWING ADOPTION TO BOOST MARKET
6.6 RESPIRATORY DEVICES
- 6.6.1 RISING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE DEMAND
6.7 INFUSION PUMPS
- 6.7.1 RISK OF SECURITY BREACHES TO IMPACT MARKET GROWTH
6.8 FETAL MONITORING DEVICES
- 6.8.1 GROWING EMPHASIS ON FETAL HEALTH TO DRIVE MARKET GROWTH
6.9 NEUROLOGICAL DEVICES
- 6.9.1 TECHNOLOGICAL ADVANCEMENTS TO BOOST MARKET
6.10 VENTILATORS
- 6.10.1 HIGH DEMAND FOR INTENSIVE CARE TO DRIVE MARKET GROWTH
6.11 ANESTHESIA MACHINES
- 6.11.1 INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET
6.12 HEARING DEVICES
- 6.12.1 RISING ADOPTION OF ADVANCED AIDS TO BOOST MARKET
6.13 OTHER IOT MEDICAL DEVICES

7 IOT MEDICAL DEVICES MARKET, BY TYPE

7.1 INTRODUCTION
7.2 STATIONARY DEVICES
- 7.2.1 IMPROVED DATA ACCESSIBILITY TO DRIVE DEMAND
7.3 IMPLANTABLE DEVICES
- 7.3.1 INCREASING INCIDENCE OF CVD AND NEUROLOGICAL DISEASES TO DRIVE DEMAND
7.4 WEARABLE DEVICES
- 7.4.1 RISING USE IN HOME CARE SETTINGS TO PROPEL MARKET
7.5 OTHER DEVICE TYPES

8 IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY

8.1 INTRODUCTION
8.2 WI-FI
- 8.2.1 ABILITY TO PROVIDE GREATER FLEXIBILITY TO CAREGIVERS TO SUPPORT MARKET GROWTH
8.3 BLUETOOTH
- 8.3.1 SEAMLESS CONNECTION BETWEEN WIRELESS DEVICES TO FOSTER ADOPTION
8.4 ZIGBEE
- 8.4.1 SECURITY CONCERNS TO LIMIT ADOPTION
8.5 OTHER CONNECTIVITY TECHNOLOGIES

9 IOT MEDICAL DEVICES MARKET, BY END USER

9.1 INTRODUCTION
9.2 HOSPITALS & CLINICS
- 9.2.1 NEED TO REDUCE HEALTHCARE COSTS TO DRIVE MARKET
9.3 NURSING HOMES, ASSISTED LIVING FACILITIES, LONG-TERM CARE CENTERS, AND HOME CARE SETTINGS
- 9.3.1 INCREASING GERIATRIC POPULATION TO CONTRIBUTE TO SEGMENT GROWTH
9.4 OTHER END USERS

10 IOT MEDICAL DEVICES MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 10.2.2 US
  - 10.2.2.1 High adoption of connected devices to drive market
- 10.2.3 CANADA
  - 10.2.3.1 Government investments in health-related technologies to boost market
10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 10.3.2 GERMANY
  - 10.3.2.1 Government initiatives to boost market
- 10.3.3 UK
  - 10.3.3.1 High penetration of wearables to drive market
- 10.3.4 FRANCE
  - 10.3.4.1 Government support for e-Health to drive market
- 10.3.5 ITALY
  - 10.3.5.1 Widespread use of mobile devices to drive market
- 10.3.6 SPAIN
  - 10.3.6.1 Growing geriatric population to propel demand
- 10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 10.4.2 CHINA
  - 10.4.2.1 High burden of chronic disorders to drive demand
- 10.4.3 JAPAN
  - 10.4.3.1 Demand from large geriatric population to boost market
- 10.4.4 INDIA
  - 10.4.4.1 Growing adoption of telemedicine to boost market
- 10.4.5 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 10.5.2 BRAZIL
  - 10.5.2.1 Increasing government initiatives to drive market
- 10.5.3 MEXICO
  - 10.5.3.1 Focus on digitalization of healthcare to support market
- 10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
- 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 10.6.2 GCC COUNTRIES
- 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IOT MEDICAL DEVICES MARKET
11.3 REVENUE ANALYSIS, 2024
11.4 MARKET SHARE ANALYSIS, 2024
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
  - 11.5.5.1 Company footprint
  - 11.5.5.2 Region footprint
  - 11.5.5.3 Product footprint
  - 11.5.5.4 Type footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 RESPONSIVE COMPANIES
- 11.6.3 DYNAMIC COMPANIES
- 11.6.4 STARTING BLOCKS
- 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  - 11.6.5.1 Detailed list of key startups/SMEs
11.7 VALUATION & FINANCIAL METRICS
- 11.7.1 FINANCIAL METRICS
- 11.7.2 COMPANY VALUATION
11.8 BRAND/SOFTWARE COMPARISON
11.9 COMPETITIVE SCENARIO
- 11.9.1 PRODUCT LAUNCHES
- 11.9.2 DEALS
- 11.9.3 EXPANSIONS

12 COMPANY PROFILES

12.1 KEY COMPANIES
- 12.1.1 MEDTRONIC
  - 12.1.1.1 Business overview
  - 12.1.1.2 Products offered
  - 12.1.1.3 Recent developments
    - 12.1.1.3.1 Product launches & approvals
    - 12.1.1.3.2 Deals
    - 12.1.1.3.3 Other developments
  - 12.1.1.4 MnM view
    - 12.1.1.4.1 Key strengths/Right to win
    - 12.1.1.4.2 Strategic choices
    - 12.1.1.4.3 Weaknesses and competitive threats
- 12.1.2 GE HEALTHCARE
  - 12.1.2.1 Business overview
  - 12.1.2.2 Products offered
  - 12.1.2.3 Recent developments
    - 12.1.2.3.1 Product launches & approvals
    - 12.1.2.3.2 Deals
  - 12.1.2.4 MnM view
    - 12.1.2.4.1 Key strengths/Right to win
    - 12.1.2.4.2 Strategic choices
    - 12.1.2.4.3 Weaknesses and competitive threats
- 12.1.3 KONINKLIJKE PHILIPS N.V.
  - 12.1.3.1 Business overview
  - 12.1.3.2 Products offered
  - 12.1.3.3 Recent developments
    - 12.1.3.3.1 Product launches & enhancements
    - 12.1.3.3.2 Deals
    - 12.1.3.3.3 Other developments
  - 12.1.3.4 MnM view
    - 12.1.3.4.1 Key strengths/Right to win
    - 12.1.3.4.2 Strategic choices
    - 12.1.3.4.3 Weaknesses and competitive threats
- 12.1.4 ABBOTT
  - 12.1.4.1 Business overview
  - 12.1.4.2 Products offered
  - 12.1.4.3 Recent developments
    - 12.1.4.3.1 Product launches & approvals
    - 12.1.4.3.2 Deals
  - 12.1.4.4 MnM view
    - 12.1.4.4.1 Key strengths/Right to win
    - 12.1.4.4.2 Strategic choices
    - 12.1.4.4.3 Weaknesses and competitive threats
- 12.1.5 BOSTON SCIENTIFIC CORPORATION
  - 12.1.5.1 Business overview
  - 12.1.5.2 Products offered
  - 12.1.5.3 Recent developments
    - 12.1.5.3.1 Product launches, enhancements, and approvals
    - 12.1.5.3.2 Deals
  - 12.1.5.4 MnM view
    - 12.1.5.4.1 Key strengths/Right to win
    - 12.1.5.4.2 Strategic choices
    - 12.1.5.4.3 Weaknesses and competitive threats
- 12.1.6 OMRON CORPORATION
  - 12.1.6.1 Business overview
  - 12.1.6.2 Products offered
  - 12.1.6.3 Recent developments
    - 12.1.6.3.1 Product & service launches
    - 12.1.6.3.2 Deals
    - 12.1.6.3.3 Expansions
- 12.1.7 BAXTER INTERNATIONAL, INC.
  - 12.1.7.1 Business overview
  - 12.1.7.2 Products offered
  - 12.1.7.3 Recent developments
    - 12.1.7.3.1 Product launches & approvals
    - 12.1.7.3.2 Deals
- 12.1.8 BIOTRONIK
  - 12.1.8.1 Business overview
  - 12.1.8.2 Products offered
  - 12.1.8.3 Recent developments
    - 12.1.8.3.1 Product launches & enhancements
    - 12.1.8.3.2 Deals
- 12.1.9 JOHNSON & JOHNSON
  - 12.1.9.1 Business overview
  - 12.1.9.2 Products offered
  - 12.1.9.3 Recent developments
    - 12.1.9.3.1 Deals
- 12.1.10 NIHON KOHDEN CORPORATION
  - 12.1.10.1 Business overview
  - 12.1.10.2 Products offered
  - 12.1.10.3 Recent developments
    - 12.1.10.3.1 Product launches & approvals
    - 12.1.10.3.2 Deals
    - 12.1.10.3.3 Expansions
- 12.1.11 SIEMENS HEALTHINEERS AG
  - 12.1.11.1 Business overview
  - 12.1.11.2 Products offered
  - 12.1.11.3 Recent developments
    - 12.1.11.3.1 Product launches
    - 12.1.11.3.2 Deals
- 12.1.12 HONEYWELL INTERNATIONAL, INC.
  - 12.1.12.1 Business overview
  - 12.1.12.2 Products offered
- 12.1.13 ALIVECOR, INC.
  - 12.1.13.1 Business overview
  - 12.1.13.2 Products offered
  - 12.1.13.3 Recent developments
    - 12.1.13.3.1 Product & service launches
    - 12.1.13.3.2 Deals
- 12.1.14 DRAGERWERK AG & CO. KGAA
  - 12.1.14.1 Business overview
  - 12.1.14.2 Products offered
  - 12.1.14.3 Recent developments
    - 12.1.14.3.1 Product launches
    - 12.1.14.3.2 Deals
- 12.1.15 NONIN
  - 12.1.15.1 Business overview
  - 12.1.15.2 Products offered
  - 12.1.15.3 Recent developments
    - 12.1.15.3.1 Product launches
    - 12.1.15.3.2 Deals
- 12.1.16 RESMED
  - 12.1.16.1 Business overview
  - 12.1.16.2 Products offered
  - 12.1.16.3 Recent developments
    - 12.1.16.3.1 Product launches
    - 12.1.16.3.2 Deals
    - 12.1.16.3.3 Expansions
    - 12.1.16.3.4 Other developments
- 12.1.17 MASIMO
  - 12.1.17.1 Business overview
  - 12.1.17.2 Products offered
  - 12.1.17.3 Recent developments
    - 12.1.17.3.1 Product launches & approvals
    - 12.1.17.3.2 Deals
- 12.1.18 I-SENS, INC.
  - 12.1.18.1 Business overview
  - 12.1.18.2 Products offered
  - 12.1.18.3 Recent developments
    - 12.1.18.3.1 Product launches & approvals
    - 12.1.18.3.2 Deals
    - 12.1.18.3.3 Expansions
- 12.1.19 ICU MEDICAL, INC.
  - 12.1.19.1 Business overview
  - 12.1.19.2 Products offered
  - 12.1.19.3 Recent developments
    - 12.1.19.3.1 Product approvals
    - 12.1.19.3.2 Deals
12.2 OTHER PLAYERS
- 12.2.1 AMD GLOBAL TELEMEDICINE
- 12.2.2 IHEALTH LABS
- 12.2.3 AEROTEL MEDICAL SYSTEMS
- 12.2.4 HUNTLEIGH HEALTHCARE LIMITED
- 12.2.5 INFINIUM MEDICAL
- 12.2.6 HAMILTON MEDICAL

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS